TERIFLUNOMIDE for Primary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where TERIFLUNOMIDE was used for Primary progressive multiple sclerosis.
Most Reported Side Effects for TERIFLUNOMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Alopecia | 5,441 | 13.9% | 28 | 611 |
| Multiple sclerosis relapse | 4,745 | 12.1% | 39 | 1,012 |
| Fatigue | 4,257 | 10.8% | 39 | 692 |
| Diarrhoea | 4,175 | 10.6% | 46 | 680 |
| Fall | 2,878 | 7.3% | 41 | 771 |
| Hypoaesthesia | 2,851 | 7.3% | 24 | 540 |
| Headache | 2,651 | 6.8% | 24 | 435 |
| Paraesthesia | 2,472 | 6.3% | 19 | 416 |
| Drug ineffective | 2,469 | 6.3% | 16 | 250 |
| Nausea | 2,311 | 5.9% | 34 | 464 |
| Gait disturbance | 2,074 | 5.3% | 27 | 572 |
| Pain | 1,985 | 5.1% | 21 | 467 |
| Multiple sclerosis | 1,983 | 5.1% | 24 | 337 |
| Condition aggravated | 1,796 | 4.6% | 20 | 392 |
| Depression | 1,612 | 4.1% | 18 | 283 |
Other Indications for TERIFLUNOMIDE
Multiple sclerosis (29,963)
Product used for unknown indication (1,438)
Relapsing-remitting multiple sclerosis (1,320)
Multiple sclerosis relapse (216)
Illness (153)
Relapsing multiple sclerosis (111)
Secondary progressive multiple sclerosis (37)
Demyelination (19)
Rheumatoid arthritis (19)
Migraine (18)
Other Drugs Used for Primary progressive multiple sclerosis
OCRELIZUMAB (6,156)
RITUXIMAB (147)
DALFAMPRIDINE (71)
FINGOLIMOD (66)
SIPONIMOD (60)
UNSPECIFIED INGREDIENT (34)
OFATUMUMAB (32)
GLATIRAMER (30)
INTERFERON BETA-1A (27)
NATALIZUMAB (27)